Label: SENNOSIDES tablet, film coated

  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: OTC monograph not final

DISCLAIMER: Most OTC drugs are not reviewed and approved by FDA, however they may be marketed if they comply with applicable regulations and policies. FDA has not evaluated whether this product complies.

Drug Label Information

Updated March 17, 2022

If you are a consumer or patient please visit this version.

  • Drug Facts

    Active ingredient (in each tablet)

    Sennosides 8.6 mg

  • PURPOSE

    Purpose

    Laxative

  • Uses

    ■ relieves occasional constipation (irregularity)

    ■ generally produces a bowel movement in 6-12 hours

  • WARNINGS

    Do not use

    ■ laxative products for longer than 1 week unless directed by a doctor

    Ask a doctor before use if you have

    ■ stomach pain

    ■ nausea

    ■ vomiting

    ■ noticed a sudden change in bowel habits that continues over a period of 2 weeks

    Stop use and ask a doctor if you have rectal bleeding or fail to have a bowel movement after use of a laxative.

    These may indicate a serious condition.

    If pregnant or breast-feeding, ask a health professional before use.

    Keep out of reach of children.

    In case of overdose, get medical help or contact a Poison Control Center right away. 1-800-222-1222

  • Directions

    ■ take preferably at bedtime or as directed by a doctor

    AgeStarting DosageMaximum Dosage

    adults and children 12 years of age

    and over

    2 tablets once a day

    4 tablet twice a day

    children 6 to under 12 years

    1 tablets once a day

    2 tablets once a day

    children 2 to under 6 years

    1/2 tablet once a day

    1 tablet twice a day

    children under 2 years

    ask a doctor

    ask a doctor

  • Other information

    • each tablet contains: calcium 25 mg
    • each tablet contains: sodium 1 mg
    • store at 25ºC (77ºF); excursions permitted between 15º-30ºC (59º-86ºF)
  • INACTIVE INGREDIENT

    croscarmellose sodium, dicalcium phosphate, hypromellose, magnesium stearate, maltodextrin, microcrystalline cellulose, mineral oil, polyethylene glycol, talc

  • Questions or comments?

    Call 1-800-231-4670 Monday-Friday 9AM-5PM EST

  • SPL UNCLASSIFIED SECTION

    TAMPER EVIDENT: DO NOT USE IF PRINTED SAFETY SEAL UNDER CAP IS BROKEN OR MISSING.

    Repackaged and Distributed By:

    Remedy Repack, Inc.

    625 Kolter Dr. Suite #4 Indiana, PA 1-724-465-8762

  • PRINCIPAL DISPLAY PANEL

    DRUG: Sennosides

    GENERIC: Sennosides

    DOSAGE: TABLET, FILM COATED

    ADMINSTRATION: ORAL

    NDC: 70518-3387-0

    NDC: 70518-3387-1

    NDC: 70518-3387-2

    NDC: 70518-3387-3

    COLOR: brown

    SHAPE: ROUND

    SCORE: No score

    SIZE: 9 mm

    IMPRINT: 1122;1122

    PACKAGING: 1 in 1 POUCH

    OUTER PACKAGING: 100 in 1 BOX

    PACKAGING: 1 in 1 POUCH

    OUTER PACKAGING: 100 in 1 BOX

    ACTIVE INGREDIENT(S):

    • SENNOSIDES 8.6mg in 1

    INACTIVE INGREDIENT(S):

    • POLYETHYLENE GLYCOL 400
    • MICROCRYSTALLINE CELLULOSE
    • HYPROMELLOSES
    • MAGNESIUM STEARATE
    • CROSCARMELLOSE SODIUM
    • LIGHT MINERAL OIL
    • TALC
    • MALTODEXTRIN
    • DIBASIC CALCIUM PHOSPHATE DIHYDRATE

    Remedy_Label

    MM2

    MM3

    MM4

  • INGREDIENTS AND APPEARANCE
    SENNOSIDES 
    sennosides tablet, film coated
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:70518-3387(NDC:70000-0447)
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    SENNOSIDES (UNII: 3FYP5M0IJX) (SENNOSIDES - UNII:3FYP5M0IJX) SENNOSIDES8.6 mg
    Inactive Ingredients
    Ingredient NameStrength
    POLYETHYLENE GLYCOL 400 (UNII: B697894SGQ)  
    MICROCRYSTALLINE CELLULOSE (UNII: OP1R32D61U)  
    HYPROMELLOSES (UNII: 3NXW29V3WO)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    CROSCARMELLOSE SODIUM (UNII: M28OL1HH48)  
    LIGHT MINERAL OIL (UNII: N6K5787QVP)  
    TALC (UNII: 7SEV7J4R1U)  
    MALTODEXTRIN (UNII: 7CVR7L4A2D)  
    DIBASIC CALCIUM PHOSPHATE DIHYDRATE (UNII: O7TSZ97GEP)  
    Product Characteristics
    ColorbrownScoreno score
    ShapeROUNDSize9mm
    FlavorImprint Code 1122;1122
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:70518-3387-0100 in 1 BOX03/15/2022
    1NDC:70518-3387-11 in 1 POUCH; Type 0: Not a Combination Product
    2NDC:70518-3387-2100 in 1 BOX03/16/2022
    2NDC:70518-3387-31 in 1 POUCH; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph not finalpart33403/15/2022
    Labeler - REMEDYREPACK INC. (829572556)